Format

Send to

Choose Destination
Int J Antimicrob Agents. 2011 Feb;37(2):102-9. doi: 10.1016/j.ijantimicag.2010.10.014. Epub 2010 Dec 4.

Confronting multidrug-resistant Acinetobacter baumannii: a review.

Author information

1
Department of Microbiology, Medical School, University of Thessaly, Larissa, Greece. ineonakis@gmail.com

Abstract

Multidrug-resistant Acinetobacter baumannii (MDR-AB) infections are difficult to treat owing to the extremely limited armamentarium. The present review reports all available treatment options against MDR-AB, including single molecules, combination schemes, and alternative modes of antimicrobial administration. Additionally, a group of recently reported peptides with anti-MDR-AB activity is described.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center